参考文献 References
[1] 宋一祎,李华茵.侵袭性肺曲霉病实验室检测方法的研究进展[J].中国临床医学,2018,25(5):804-808.
[2] NAYMA , AUVET A , MANKIKIAN J , etal. Evaluation of a flexiblebronchoscope prototype designed fobronchos -copy during mechanicalventilation: a proof-of-concept study [J]. Anaesthesia, 2017,72(6): 719 -723.
[3] GROLLAH, SHAHP M,MENTZELC,etal.Trendsin the postmor temepide miology of invasive fungal infection sata university hospital[J]. Infect, 1996, 33(1):23-32．
[4] DE PAUWB,WALSH T J, DONNELLY J P,etal.Revised definitions of invasive fungal disease from the European Organization for research ang treatment of Cancer/ Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Disease Mycoses Study Group(EORTC/MSG) Consensus Group[J]. Clin Infect DIS, 2008, 46(12):1813-1821.
[5] DONNELLY J P,CHEN S C,KAUFFMAN C A,et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium[J]. Clin Infect Dis, 2020,71(6):1367-1376.
[6] 刘昶,谢苗荣. 肺部真菌感染实验室早期诊断方式研究 [J]. 临床和实验医学杂志,2016, 15(8):821-823.
[7] MARTY F M,OSTROSKY-ZEICHNER L,CORNELY O A,et al. Lsavuconazole treatment for mucormycosis:a single-arm open-label trial and case-control analysis[J]. The Lancet Infect Dis,2016,16(7):828-837.
[8] ARVANITIS M,MYLONAKIS E. Digagnosis of invasive aspergillosis:recent gevelopments and ongoing challenges [J]. Eur J Clin Invest,2015,45(6):646-652.
[9] KAZIANIK,MITRAKOU E,DIMOPOULOS G.Improv -ing diagostic accuracy for invasive pulmonary aspergillo -sis insthe intensive careunit[J]. Ann transl Med, 2016,4 (18): 352.
[10] VERGIDSP, RAZONABLE R R, WHEAT L J,etal. Reduction in false-positive aspergillus serun galacto -mannan anzyme immunoassay results associated with use of piperacillin-tazobactam in the united states[J].J Clin Microbiol, 2014,52(6):2199-2201.
[11] DICHTL K,FORSTER J,ORMANNS S,et al. Comparison of β-D-glucan and galactomannan in serum for detection of invasive aspergillosis:retrospective analysis with focus on early diagnosis[J]. J Fungi (Basel),2020, 6(4):253.
[12] 宋一祎,李华茵. 侵袭性肺曲霉病实验室检测方法的研究进展[J]. 中国临床医学,2018,25(5):804-809.
[13] PATTERSON T F,THOMPSON G R 3rd,DENNING D W,et al. Practice guidelines for the diagnosis and management of aspergillosis:2016 update by the infections disenses society of America[J]. Clin Infect Dis,2016,63 (4):el-e60.
[14] KARAGEORGOPOULOS D E,VOULOUMANOU E K, NTZIORA F,et al. β-D-glucan assay for the diagnosis of invasive fungal infections:a meta-analysis[J]. Clin Infect Dis,2011,52(6):750-770.
[15] EIGL S,PRATTES J,LACKNER M,et al. Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients[J]. Crit Care,2015,19(1):178
[16] VIDAL-GARCÍA M,DOMINGO M P,DE RUEDA B, et al. Clinical validity of bis(methylthio)gliotoxin for the diagnosis of invasive aspergillosis[J]. Appl Microbiol Biotechnol,2016,100(5):2327-2334.
[17] ULLMANN A J,AGUADO J M,ARIKAN-AKDAGLI S,et al. Diagnosis and management of Aspergillus diseases:executive summary of the 2017 ESCMID-ECMM ERS guideline[J]. Clin Microbiol Infect,2018,24(Suppl1): e1-e38.
[18] 朱利平,翁心华. 侵袭性真菌感染的分子诊断在造血干细胞移植及血液恶性肿瘤患者中的应用[J]. 诊断学理论与实践,2010,9(1):14-18.
[19] 谢栓栓,李譞,李萍,等. 宏基因二代测序技术对感染性疾病患者的诊断价值及其临床应用[J]. 国际呼吸杂志, 2020,40(9):641-646.